Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbocyclic 5'-noruridine.

V R Hegde1, K L Seley, S W Schneller

  • 1Department of Chemistry, Auburn University, AL 36849-5312, USA.

Nucleosides, Nucleotides & Nucleic Acids
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CoFactor (Biokeys Pharmaceuticals).

IDrugs : the investigational drugs journal·2005
Same author

Selective transport of a new class of purine antimetabolites by the protozoan parasite Trypanosoma brucei.

Nucleosides, nucleotides & nucleic acids·2004
Same author

Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analogues.

Antiviral chemistry & chemotherapy·2002
Same author

"Fleximers". Design and synthesis of two novel split nucleosides.

Organic letters·2001
Same author

Lin-benzoaristeromycin.

Nucleosides, nucleotides & nucleic acids·2001
Same author

5'-Nor carbocyclic 5'-deoxy-5'-(isobutylthio)adenosine and a 2',3'-dideoxy-2',3'-didehydro derivative.

Antiviral chemistry & chemotherapy·2001
Same journal

LncRNA EGOT inhibits the proliferation of lung adenocarcinoma cells and is associated with poor prognosis.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Can the combination of 5-fluorouracil and gemcitabine increase the treatment efficacy of pancreatic and colon cancer?

Nucleosides, nucleotides & nucleic acids·2026
Same journal

"Aptamer-guided therapeutics and diagnostics for metabolic syndrome: Design, delivery, and translation of aptamer-based systems".

Nucleosides, nucleotides & nucleic acids·2026
Same journal

The impact of vitamin B12 deficiency on urinary profile of <i>de novo</i> purine synthesis intermediates: consequences of the methylfolate trap.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Evaluation of MTH1 and DCTPP1 inhibitors in fluorocyclopentenylcytosine (RX-3117) resistant lung cancer cells and potential cross resistance patterns.

Nucleosides, nucleotides & nucleic acids·2026
Same journal

Circular RNAs: promising biomarkers for diagnosis, prognosis and therapy in oral squamous cell carcinoma.

Nucleosides, nucleotides & nucleic acids·2026
See all related articles

Researchers developed a new carbocyclic 5'-noruridine (1) for novel oligomers. Its enantiomer (5) demonstrated promising antiviral activity against Epstein-Barr virus, highlighting potential therapeutic applications.

Area of Science:

  • Organic Chemistry
  • Medicinal Chemistry
  • Virology

Background:

  • Carbocyclic nucleosides are analogs of natural nucleosides with a carbon-carbon bond replacing the furanose oxygen.
  • Carbocyclic 5'-nor nucleosides are a subclass with potential applications in antiviral therapies and as building blocks for novel nucleic acid analogs.
  • The synthesis and biological evaluation of novel carbocyclic nucleosides are crucial for drug discovery.

Purpose of the Study:

  • To describe a convenient two-step preparation of (1'R,2'S,3'R,4'S)-1-(2',3',4'-trihydroxycyclopent-1'-yl)-1H-uracil (carbocyclic 5'-noruridine, 1).
  • To evaluate the antiviral properties of the synthesized carbocyclic 5'-noruridine (1) and its enantiomer (5).
  • To identify potential therapeutic agents against viral infections, specifically Epstein-Barr virus.

Main Methods:

Related Experiment Videos

  • A two-step synthesis involving a palladium complex of (+)-(1R,4S)-4-hydroxy-2-cyclopenten-1-yl acetate (3) and the sodium salt of uracil (2).
  • Characterization of the synthesized compound (1).
  • Antiviral screening of compound (1) and its enantiomer (5).

Main Results:

  • A convenient and efficient two-step synthesis of carbocyclic 5'-noruridine (1) was achieved.
  • Compound (1) and its enantiomer (5) were prepared and characterized.
  • Enantiomer (5) exhibited promising antiviral activity against Epstein-Barr virus.

Conclusions:

  • The developed synthetic route provides accessible carbocyclic 5'-noruridine (1) for further research.
  • The promising activity of enantiomer (5) against Epstein-Barr virus warrants further investigation as a potential antiviral drug candidate.
  • This study contributes to the development of novel carbocyclic nucleoside analogs for therapeutic applications.